December FLU 'ODDITIES' BREAKING NEWS

[Guest guest]

http://www.legitgov.org/flu_oddities.htmlFLU 'ODDITIES' BREAKING NEWS Last updated: Fri, 18 Dec 2009 06:39:22 GMTPetition against mandatory vaccines (6550 signatures)Flu pandemic may change US flu approach forever --School-based vaccinations a model for the future [so pharmaterrorists can make a killing] 17 Dec 2009 The swine flu pandemic may have changed the U.S. approach to handling influenza forever, and for the better, U.S. officials said on Thursday. While they said years of work were needed before vaccine production was up to the desired standard, some experiments such as vaccinating children in schools might work to help control seasonal influenza. [Penn. ready to deal with flu, terrorism 17 Dec 2009 Funding cuts threaten the nation's ability to deal with disease outbreaks and bioterrorism, but Pennsylvania is among the better-prepared states, according to a report. Pennsylvania fulfills eight of 10 key measures in the report, called "Ready or Not? Protecting the Public’s Health from Diseases, Disasters and Bioterrorism."CDC Issues Nationwide Recall of 800,000 Kids Swine Flu Vaccine Doses 15 Dec 2009 The Centers for Disease Control (CDC) are recalling selected batches of Sanofi Pasteur manufactured H1N1 vaccine for children. The 800,000 swine flu shots were made for children aged six to 35 months. Today the CDC recalls 800,000 kids' swine flu vaccine doses made by Sanofi Pasteur. The agency stresses that the recall is not related to safety concerns. Instead, the manufacturer alerted officials that the potency of the children's H1N1 vaccine was below acceptable limits.US trying to dump 70 million doses of H1N1 vaccine 08 Dec 2009 The U. S. is preparing to offer swine flu shots to everyone who wants one [LOL] in the next few weeks, a Centers for Disease Control and Prevention official said Monday. About 70 million doses of the shot have been shipped to state and local health authorities in the U. S., Anthony Fiore, associate chief of policy and liaison activities at the CDC's National Center for Immunization and Respiratory Diseases' Influenza Division, said in an interview. San Francisco-based McKesson Corp. is distributing the vaccine from manufacturers to four undisclosed sites and then on to 150,000 local sites, said Michael Angelastro of the U. S. Biomedical Advancement Research and Development Authority.Batch of H1N1 Vaccine Pulled Due to Severe Allergic Reactions 10 Dec 2009 Health officials across Canada are being asked to hold back a batch of [deadly] swine flu vaccine that appears to be causing higher rates of severe allergic reactions. The vaccine's manufacturer, GlaxoSmithKline, is asking governments to stop using vaccine doses from one particular lot shipment issued in late October.Big Pharma inside the WHO: confidential analysis of unreleased WHO Expert Working Group draft reports 09 Dec 2009 This is a confidential pharmaceutical industry trade association dossier about the WHO Expert Working Group (EWG) on R & D Financing. The compilation of documents shows the influence of "Big Pharma" on the policy making decisions of the WHO, the UN body safeguarding public health. These confidential documents were obtained by the drug industry before their public release to WHO member states (scheduled to be released May 2010).Family: Clarksville woman sick after H1N1 vaccine 09 Dec 2009 (TN) A Clarksville woman is recovering at Vanderbilt University Medical Center's Stallworth Rehabilitation Center from Guillain-Barre syndrome, an illness she says is connected to taking the H1N1 vaccination. A suspected connection between the H1N1 vaccine and GBS was evaluated by the Institute of Medicine in 2003. The institute reviewed the 1976 national campaign to administer the H1N1 vaccine, also known as swine flu vaccine. AdvertisementU.S. interest in seasonal flu shots may be waning --Only a third of U.S. adults have had shot - survey 09 Dec 2009 Americans are getting [deadly] seasonal flu shots at about the same rate as last year despite heightened awareness of the risks of influenza inspired by the swine flu pandemic, a survey released on Wednesday showed. As of the middle of November, about 32 percent of all U.S. adults and 37 percent of adults who are recommended to get a flu shot against seasonal flu had gotten one.Roche's Tamiflu Not Proven to Cut Flu Complications, Study Says 09 Dec 2009 Roche Holding AG’s antiviral drug Tamiflu may not prevent complications from influenza in healthy adults, according to a review by an independent research group that reversed its previous findings that the medicine warded off pneumonia and other deadly conditions linked to the disease... The report raises questions about how drugs are reviewed, approved and distributed, Fiona Godlee, the British journal’s editor in chief, wrote in an editorial. The studies originally used to establish the benefits of Tamiflu were written by Roche employees and paid consultants, under-reported serious side effects and failed to clearly identify all the authors, she wrote.Flu pandemic could be mildest on record 08 Dec 2009 With the second wave of H1N1 infections having crested in the United States, leading epidemiologists are predicting that the pandemic could end up ranking as the mildest since modern medicine began documenting influenza outbreaks. Experts warn that the flu is notoriously unpredictable, but several recent analyses, including one released late Monday, indicate that the death toll is likely to be far lower than the number of fatalities caused by past pandemics.Corporate employers got scarce flu vaccine 07 Dec 2009 When the swine flu vaccine was most scarce, health officials gave thousands of doses to corporate clinics at Walt Disney World, Toyota, defense contractors, oil companies and cruise lines, according to a USA TODAY review of vaccine distribution data from three states. USA TODAY examined how state health departments distributed H1N1 vaccine after public outcry last month over Wall Street firms such as Goldman Sachs receiving doses while doctors and hospitals encountered shortages. The data show other companies got the vaccine in October and early November. [On the upside, maybe the defense contractors and Goldman Suchs executives received Baxter's batch.]Flu pandemic could be mildest on record 08 Dec 2009 With the second wave of H1N1 infections having crested in the United States, leading epidemiologists are predicting that the pandemic could end up ranking as the mildest since modern medicine began documenting influenza outbreaks. Experts warn that the flu is notoriously unpredictable, but several recent analyses, including one released late Monday, indicate that the death toll is likely to be far lower than the number of fatalities caused by past pandemics.Corporate employers got scarce flu vaccine 07 Dec 2009 When the swine flu vaccine was most scarce, health officials gave thousands of doses to corporate clinics at Walt Disney World, Toyota, defense contractors, oil companies and cruise lines, according to a USA TODAY review of vaccine distribution data from three states. USA TODAY examined how state health departments distributed H1N1 vaccine after public outcry last month over Wall Street firms such as Goldman Sachs receiving doses while doctors and hospitals encountered shortages. The data show other companies got the vaccine in October and early November. [On the upside, maybe the defense contractors and Goldman Suchs executives received Baxter's batch.]Warning over second child swine-flu jab --High fever, drowsiness and loss of appetite are side-effects, say regulators 05 Dec 2009 Children having their second dose of the swine flu jab may develop a high fever, European regulators have warned. Parents and doctors are being urged to keep watch on a child's temperature after research found they were more likely to suffer a fever above 38C (100F) after the second dose compared with after the first. Children were also more likely to suffer soreness at the site of injection as well as drowsiness, irritability and loss of appetite after the second dose. Experts at the European Medicines Agency (EMEA) said the "findings were unexpected, as they were not seen with the mock-up vaccine".Schools to get masks, gloves to help prevent spread of flu --Millions of them, purchased with federal grants, will be distributed throughout California for use by ill students and the nurses who examine them. 04 Dec 2009 Millions of protective masks and gloves will be distributed to schools throughout California to prevent the spread of swine and seasonal flu, state and county officials announced Friday. Purchased with federal grants, the 23 million masks and gloves will be used by ill students as well as the nurses who examine them.Heads up! HHS sociopaths want billion$ for US pharmaterrorists to make new vaccines using dog cells and genetically engineered E.Coli. U.S. health-threat response to be reviewed 02 Dec 2009 Citing the balky swine flu vaccination campaign and other shortcomings in the nation's medical defenses, a top Obama administration official has announced a major review of the government's efforts to develop new protections against pandemics, bioterrorism and other health threats. "Today, we face a wider range of public health threats than ever before in our history," Sebelius said. "It could be [Fort Detrick] anthrax delivered in an envelope. It could be a [blackwater] dirty bomb set off in a subway car. It could be a new [baxter] strain of flu that our bodies have no immunity to."Conn. AG probes flu drug prices 01 Dec 2009 Connecticut Attorney General Richard Blumenthal has begun asking major pharmacies for details about their Tamiflu pricing policies as part of an investigation into complaints of erratic and excessive prices for the flu drug. Blumenthal has asked CVS Caremark Corporation, Rite Aid Corporation and Walgreen Co., for immediate information, including details about their current prices and prices pre-dating the current H1N1 flu pandemic and ensuing Tamiflu shortage. =====In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.